Skip to main content
. 2022 Feb;84(1):169–179. doi: 10.18999/nagjms.84.1.169

Table 2.

Background characteristics of 2-week responders and non-responders

Variable Responder Non-responder P-value
N 10 8
Male/ Female 6/4 6/2 0.63
Age, median ± range 38 ± 14 34 ± 16 0.59
Body weight, kg, median ± range 57 ± 7 53 ± 12 0.32
Disease duration (month), median ± range 51 ± 43 58 ± 59 0.82
Disease type: Extensive/ left-sided 7/3 7/1 0.58
In-patient/ out-patient 4/6 6/2 0.18
History of emergency hospitalization, mean times 1.1 2.0 0.02
Lichtiger index ± SD 8.2 ± 1.8 8.6 ± 1.5 0.44
UCEIS 5.3 ± 1.2 5.5 ± 0.9 0.68
Hemoglobin (g/dL) 12.2 ± 1.2 10.5 ± 1.1 0.05
Albumin (g/dL) 3.5 ± 0.6 3.1 ± 0.7 0.34
C-reactive protein (mg/dL) 1.0 ± 1.7 1.4 ± 1.0 0.13
Corticosteroid: Dependent/ refractory 5/5 3/5 0.99
Use of immunomodulator/ non-use 2/8 2/6 0.99
Previous biologics failure/ naïve 8/2 7/1 0.99
Previous biologics double or triple failure/ single failure or naïve 3/7 6/2 0.15
Previous calcineurin inhibitor failure/ naïve 2/8 6/2 0.05